BASES FISIOPATOLÓGICAS Y TERAPEÚTICAS EN ENFERMEDADES AUTOINMUNES
BAFITEA
![Foto de BASES FISIOPATOLÓGICAS Y TERAPEÚTICAS EN ENFERMEDADES AUTOINMUNES](/img/grupo.png)
![Foto de Hospital de Galdakao - Usansolo](/img/noimage_org.png)
Hospital de Galdakao - Usansolo
Galdácano, EspañaHospital de Galdakao - Usansolo-ko ikertzaileekin lankidetzan egindako argitalpenak (9)
2022
-
Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients
Clinical and Experimental Rheumatology
2021
-
Long-term Follow-up and optimization of infliximab in refractory uveitis due to Behçet Disease: National study of 103 white patients
Journal of Rheumatology, Vol. 48, Núm. 5, pp. 741-750
2013
-
A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 31, Núm. SUPPL.75
-
Evidence of association of the NLRP1 gene with giant cell arteritis
Annals of the Rheumatic Diseases
-
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886
2012
-
Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population
Clinical and Experimental Rheumatology, Vol. 30, Núm. SUPPL. 70
-
Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis
Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279
2011
-
A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis
Journal of Rheumatology, Vol. 38, Núm. 12, pp. 2598-2601
-
Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis
Human Immunology, Vol. 72, Núm. 5, pp. 458-461